Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma

2017 ◽  
Vol 47 (11) ◽  
pp. 1196-1205 ◽  
Author(s):  
Mayumi Egawa ◽  
Yuichi Yoshida ◽  
Satoshi Ogura ◽  
Tomohide Kurahashi ◽  
Takashi Kizu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Transcription Factor ◽  
Poor Prognosis ◽  
Clinicopathological Features ◽  
Human Hepatocellular Carcinoma ◽  
Forkhead Box ◽  
Forkhead Box M1

Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma

Tumor Biology ◽  
2015 ◽  
Vol 36 (12) ◽  
pp. 9373-9383 ◽  
Author(s):  
Haijian Zhang ◽  
Min Yao ◽  
Wei Wu ◽  
Liwei Qiu ◽  
Wenli Sai ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Poor Prognosis ◽  
Annexin A2 ◽  
Clinicopathological Features

Forkhead box M1 (FOXM1) transcription factor is a key oncogenic driver of aggressive human meningioma progression

2019 ◽  
Vol 46 (2) ◽  
pp. 125-141 ◽  
Author(s):  
H. Kim ◽  
K.‐J. Park ◽  
B.‐K. Ryu ◽  
D.‐H. Park ◽  
D.‐S. Kong ◽  
...  
Keyword(s):  
Transcription Factor ◽  
Human Meningioma ◽  
Forkhead Box ◽  
Forkhead Box M1 ◽  
Oncogenic Driver

scholarly journals Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma

Oncotarget ◽  
2018 ◽  
Vol 9 (30) ◽  
pp. 21022-21035 ◽  
Author(s):  
Satoshi Ogura ◽  
Yuichi Yoshida ◽  
Tomohide Kurahashi ◽  
Mayumi Egawa ◽  
Kunimaro Furuta ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Transcription Factor ◽  
Therapeutic Approach ◽  
Mevalonate Pathway ◽  
Human Hepatocellular Carcinoma ◽  
Novel Therapeutic
Sign in / Sign up

Export Citation Format

Share Document